# Phase I Clinical Trial of Enterovirus Type71 - Coxsackievirus Type A16 Bivalent Vaccine

> **NCT07326878** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Institute of Medical Biology, Chinese Academy of Medical Sciences** · enrollment: 144 (estimated)

## Conditions studied

- Hand, Foot and Mouth Disease (HFMD)
- HFMD
- Hand, Foot and Mouth Disease

## Interventions

- **BIOLOGICAL:** Low Dose Enterovirus Type71 - Coxsackievirus Type A16 bivalent vaccine, inactivated (human diploid cell)
- **BIOLOGICAL:** Medium Dose Enterovirus Type71 - Coxsackievirus Type A16 bivalent vaccine, inactivated (human diploid cell)
- **BIOLOGICAL:** High Dose Enterovirus Type71 - Coxsackievirus Type A16 bivalent vaccine, inactivated (human diploid cell)
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT07326878
- **Lead sponsor:** Institute of Medical Biology, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-30
- **Primary completion:** 2026-08-15
- **Final completion:** 2027-08-15
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2026-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07326878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07326878, "Phase I Clinical Trial of Enterovirus Type71 - Coxsackievirus Type A16 Bivalent Vaccine". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07326878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*